| MEDI | Monday, 29 August 2005 | ||
8:30 AM-12:00 PM Washington DC Convention Center -- Ballroom A, Oral | |||
Graduate Fellowship and David W. Robertson Award Symposium | |||
| Organizer: | Bharat K. Trivedi | ||
| Organizer, Presiding: | Daniel L. Flynn | ||
| 8:30 AM | 222 | Validation and drug targeting of aurora kinase for the treatment of pancreatic cancer Steven L. Warner, Sridevi Bashyam, Hariprasad Vankayalapati, David J. Bearss, Haiyong Han, Daniel D. Von Hoff, Laurence H. Hurley | |
| 8:55 AM | 223 | Approaches to the synthesis of Lomaiviticin A Evan S. Krygowski, John D. Freed, Kerry Benenato, Matthew D. Shair | |
| 9:20 AM | 224 | Synthesis and structure-activity relationship studies of complex peptidyl nucleoside antibiotics Christina S. Stauffer, Apurba Datta | |
| 9:45 AM | 225 | AEI:Structure-based design of okadaic acid-derived protein phosphatase inhibitors David A. Colby, A. Richard Chamberlin | |
| 10:10 AM | 226 | Developing methods to incorporate protein flexibility into drug design: HIV-1 protease as a test system Kristin L. Meagher, Heather A. Carlson | |
| 10:35 AM | 227 | Function oriented synthesis: The design, synthesis, and biological evaluation of a structurally and functionally unique class of therapeutic leads for cancer treatment Jeremy L. Baryza, Paul A. Wender | |
| 11:00 AM | Introduction of David Robertson Awardee | ||
| 11:10 AM | 228 | The role of the medicinal chemist in drug discovery: Controlling the controllables Don Middleton | |
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
The 230th ACS National Meeting, in Washington, DC, Aug 28-Sept 1, 2005